{'text': 'Pfizer CEO Contemplates $42 Billion Tax Hit As Pfallergan Deal Inspires Corporate Tax Discussions', 'publisher': {'href': 'https://www.biospace.com', 'title': 'BioSpace'}, 'created_at': 'Mon, 30 Nov 2015 08:00:00 GMT', 'description': 'Pfizer CEO Contemplates $42 Billion Tax Hit As Pfallergan Deal Inspires Corporate Tax Discussions  BioSpace', 'url': 'https://news.google.com/rss/articles/CBMiwwFBVV95cUxOc2d1TWVyeHFQcVFEcThPekEtMVVHc05JaTZocWhOV1huNkg1SGFOeDJfTUFLd0w3MWpscVNFUHlFdkc0UGlKLU9ETzFORG5CVUd4cklCd21ja2JKeHE1QkNEYTBBcXBtcE1TZG1aZzhZX1NPX1R3dDhYekp2VWJuSFhPR2Y1Vy1CODJCWEdfX2pjOE9xX2pGQl9jVXkzM1IzTHZJNTh1VTBielgyVm9GTnVJUG1PM0JOM1ZudHNmRC15Mnc?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Some Topical Anti-Inflammatory Drugs Can Rival Oral Versions', 'publisher': {'href': 'http://www.wsj.com', 'title': 'The Wall Street Journal'}, 'created_at': 'Mon, 30 Nov 2015 08:00:00 GMT', 'description': 'Some Topical Anti-Inflammatory Drugs Can Rival Oral Versions  The Wall Street Journal', 'url': 'https://news.google.com/rss/articles/CBMioAFBVV95cUxQTDU0cnBFaFJEZ3B4cmItU2FDdlhhZkRka2N2cTY2R3VhV190S2pBSjhxMlA2d0JOQV9WYWFmVUU5VmM4TmpQWUtPTnNJRVNDV3BUTXRLcG81TjRRZEVGeTNCU25jY3FJRDc2eUs5bGhma00taExQRTZQMHNUTHpTSmJQMTJpTExQRl83QmNrYUtSTU96ZG1YRzZ2X2dpMVdM?oc=5&hl=en-US&gl=US&ceid=US:en'}
